查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1279647

2022-2029年全球精准医疗市场规模研究和预测，按技术和应用及区域分析

Global Precision Medicine Market Size study & Forecast, by Technology by Application, and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

精准医学是一门新兴的科学，它将治疗决定集中在病人的基因特征、生活方式和环境上。精准医学在治疗癌症方面的成功导致了它的普及。它使医学专家和研究人员能够预测每一种具体疾病的更精确的治疗和预防措施。精准医学专注于将健康的身体细胞变成癌细胞的突变，通常被称为个性化医学或定制医学。与传统药物相比，精准医学在癌症靶向治疗中的应用提供了更少的不良反应，促进了更快的康复。由于中枢神经系统疾病发病率的增加和癌症生物学的进步等因素，精准医学市场正在扩大。

由于包括癌症和不常见疾病在内的严重疾病发病率的上升，这一领域已经产生了一些基因疗法、诊断法和药物。根据国际癌症研究机构（IARC）的估计，在全球范围内，2018年有1700万个新的癌症病例和950万个癌症相关的死亡病例。据估计，到2040年，全世界的癌症负担将增加到2750万新病例。此外，细胞生物学和技术的发展正在推动审查中的行业的发展。例如，2021年5月，AdventHealth推出了一个数据驱动的精准医疗倡议，作为其基因组学计划扩展的一部分。这项倡议组织和整合纵向病人数据与分子测试数据，从而建立一个数据集和疾病网络模型，帮助医疗系统更好地预测疾病的发生以及它们对治疗的反应。因此，这些发展正在推动增长。此外，精准医疗的技术进步和与精准医疗相关的投资增长正在为市场创造一个有利可图的增长。然而，精准医疗发展的高成本阻碍了市场增长。

全球精准医疗市场研究的主要地区包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于品牌技术的主导地位和该地区日益增长的疾病流行率，北美在收入方面主导了市场。而亚太地区在预测期内预计将以最高的复合年增长率增长，原因是老年病的增加、药品开发合作数量的增加、主要参与者的地理扩张以及政府和非营利组织在市场空间的积极参与等因素。

该研究的目的是确定近年来不同领域和国家的市场规模，并对未来几年的价值进行预测。该报告旨在将研究涉及的国家内的行业的定性和定量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，以及对竞争格局和主要参与者的技术产品的详细分析。.

目录

第一章：执行摘要

  • 市场简介
  • 2019-2029年全球和细分市场的估计和预测
    • 2019-2029年精准医疗市场，按地区划分
    • 2019-2029年精准医疗市场，按技术划分
    • 2019-2029年精准医疗市场，按应用划分
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球精准医疗市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 研究的范围
    • 行业演变
  • 研究考虑的年份
  • 货币兑换率

第三章：全球精准医疗市场动态

  • 精准医疗市场影响分析（2019-2029年）
    • 市场驱动力
      • 中枢神经系统疾病的发病率不断上升
      • 癌症生物学的进步
    • 市场挑战
      • 精准医疗发展的高成本
    • 市场机会
      • 精准医疗的技术进步
      • 与精准医疗相关的投资不断增长

第四章：全球精准医疗市场行业分析

  • 波特的5力模型
    • 供应商的讨价还价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力模型的未来方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 经济
    • 社会
    • 技术
  • 最佳投资机会
  • 最佳策略
  • 行业专家展望
  • 分析师建议和结论

第五章：风险评估：COVID-19的影响

  • 评估COVID-19对行业的整体影响
  • COVID-19前和COVID-19后的市场情况

第六章：全球精准医疗市场，按技术分类

  • 市场简介
  • 按技术分類的全球精准医疗市场，性能-潜力分析
  • 2019-2029年全球精准医疗市场按技术的估计和预测
  • 精准医疗市场，细分领域分析
    • 大数据分析
    • 生物信息学
    • 基因测序
    • 药物发现
    • 伴随诊断
    • 其他技术

第7章 ：全球精准医疗市场，按应用分类

  • 市场简介
  • 全球精准医疗市场，按应用，性能 - 潜力分析
  • 2019-2029年全球精准医疗市场按应用估计和预测的情况
  • 精准医疗市场，细分领域分析
    • 肿瘤学
    • 中枢神经系统
    • 免疫学
    • 呼吸系统
    • 其他应用

第八章：全球精准医疗市场，区域分析

  • 精准医疗市场，区域市场简介
  • 北美洲
    • 美国
      • 技术细分估计和预测，2019-2029年
      • 2019-2029年应用细分估计和预测
    • 加拿大
  • 欧洲精准医疗市场简介
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区精准医疗市场简述
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉美地区精准医疗市场简介
    • 巴西
    • 墨西哥
    • 拉美其他地区
  • 世界其他地区

第九章：竞争情报

  • 顶级市场战略
  • 公司简介
    • Astarte Medical
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • AstraZeneca PLC
    • F Hoffmann-La Roche Ltd.
    • Laboratory Corporation of America Holdings
    • Medtronic PLC
    • Myriad Genetics Inc.
    • Novartis AG
    • Pfizer Inc.
    • Qiagen NV
    • Quest Diagnostics

第十章 ：研究过程

  • 研究过程
    • 资料探勘
    • 数据分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Precision Medicine Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Precision medicine is an emerging science that focuses treatment decisions on a patient's genetic profile, way of life, and environment. The success of precision medicine in treating cancer has led to an increase in its popularity. It enables medical professionals and researchers to forecast more precise treatment and prevention measures for every specific disease. Precision medicine, which focuses on the mutations that turn healthy bodily cells into cancerous ones, is often referred to as personalized medicine or tailored medicine. In comparison to conventional medications, the use of precision medicine in targeted cancer treatment offers fewer adverse effects and promotes faster recovery. The Precision Medicine market is expanding because of factors such as increasing incidence of central nerves system disorders and advancement in cancer biology.

Several gene therapies, diagnostics, and medications have been created in this field as a result of the rise in the prevalence of serious illnesses including cancer and uncommon diseases. According to estimates from the International Agency for Research on Cancer (IARC), globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018. It is estimated to increase the worldwide burden of cancer to 27.5 million new cases by 2040. Furthermore, the development of the industry under review is being fueled by developments in cell biology and technology. For instance, in May 2021, AdventHealth launched a data-driven precision medicine initiative as part of the expansion of its genomics programme. This initiative organize and integrate longitudinal patient data with molecular testing data, resulting in the creation of a dataset and disease network models that will aid the healthcare system in better anticipating the onset of diseases and how they will respond to treatments. Thus, these developments are fueling the growth. In addition, higher technological advancements of precision medicine and growing investments associated with precision medicine is creating a lucrative growth to the market. However, high cost for precision medicine development halt market growth.

The key regions considered for the Global Precision Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded Technologies and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric, an increase in the number of collaborations for medicine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Astarte Medical
  • AstraZeneca PLC
  • F Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings
  • Medtronic PLC
  • Myriad Genetics Inc.
  • Novartis AG
  • Pfizer Inc.
  • Qiagen NV
  • Quest Diagnostics

Recent Developments in the Market:

  • In November 2022, The University of Pecs (UP) and BGI Genomics decided to open a collaborative lab in Hungary. The collaborative lab will begin formal operations in order to strengthen BGI Genomics' and the UP's avant-garde precision medicine advancements in the Central and Eastern European region and to speed the development of genomic sequencing and clinical diagnostic services.

Global Precision Medicine Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Technology, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Technology:

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Other Technologies

By Application:

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Other Applications

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Precision Medicine Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Precision Medicine Market, by Technology, 2019-2029 (USD Billion)
    • 1.2.3. Precision Medicine Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Precision Medicine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Precision Medicine Market Dynamics

  • 3.1. Precision Medicine Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of Central Nerves System disorders
      • 3.1.1.2. Advancement in Cancer Biology
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost for precision medicine development
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Higher Technological Advancements of Precision Medicine
      • 3.1.3.2. Growing Investments Associated with Precision Medicine

Chapter 4. Global Precision Medicine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Precision Medicine Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Precision Medicine Market by Technology, Performance - Potential Analysis
  • 6.3. Global Precision Medicine Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
  • 6.4. Precision Medicine Market, Sub Segment Analysis
    • 6.4.1. Big Data Analytics
    • 6.4.2. Bioinformatics
    • 6.4.3. Gene Sequencing
    • 6.4.4. Drug Discovery
    • 6.4.5. Companion Diagnostics
    • 6.4.6. Other Technologies

Chapter 7. Global Precision Medicine Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Precision Medicine Market by Application, Performance - Potential Analysis
  • 7.3. Global Precision Medicine Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Precision Medicine Market, Sub Segment Analysis
    • 7.4.1. Oncology
    • 7.4.2. CNS
    • 7.4.3. Immunology
    • 7.4.4. Respiratory
    • 7.4.5. Other Applications

Chapter 8. Global Precision Medicine Market, Regional Analysis

  • 8.1. Precision Medicine Market, Regional Market Snapshot
  • 8.2. North America Precision Medicine Market
    • 8.2.1. U.S. Precision Medicine Market
      • 8.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Precision Medicine Market
  • 8.3. Europe Precision Medicine Market Snapshot
    • 8.3.1. U.K. Precision Medicine Market
    • 8.3.2. Germany Precision Medicine Market
    • 8.3.3. France Precision Medicine Market
    • 8.3.4. Spain Precision Medicine Market
    • 8.3.5. Italy Precision Medicine Market
    • 8.3.6. Rest of Europe Precision Medicine Market
  • 8.4. Asia-Pacific Precision Medicine Market Snapshot
    • 8.4.1. China Precision Medicine Market
    • 8.4.2. India Precision Medicine Market
    • 8.4.3. Japan Precision Medicine Market
    • 8.4.4. Australia Precision Medicine Market
    • 8.4.5. South Korea Precision Medicine Market
    • 8.4.6. Rest of Asia Pacific Precision Medicine Market
  • 8.5. Latin America Precision Medicine Market Snapshot
    • 8.5.1. Brazil Precision Medicine Market
    • 8.5.2. Mexico Precision Medicine Market
    • 8.5.3. Rest of Latin America Precision Medicine Market
  • 8.6. Rest of The World Precision Medicine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Astarte Medical
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. AstraZeneca PLC
    • 9.2.3. F Hoffmann-La Roche Ltd.
    • 9.2.4. Laboratory Corporation of America Holdings
    • 9.2.5. Medtronic PLC
    • 9.2.6. Myriad Genetics Inc.
    • 9.2.7. Novartis AG
    • 9.2.8. Pfizer Inc.
    • 9.2.9. Qiagen NV
    • 9.2.10. Quest Diagnostics

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Precision Medicine Market, report scope
  • TABLE 2. Global Precision Medicine Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Precision Medicine Market estimates & forecasts by Technology 2019-2029 (USD Billion)
  • TABLE 4. Global Precision Medicine Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Precision Medicine Market
  • TABLE 70. List of primary sources, used in the study of global Precision Medicine Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Precision Medicine Market, research methodology
  • FIG 2. Global Precision Medicine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Precision Medicine Market, key trends 2021
  • FIG 5. Global Precision Medicine Market, growth prospects 2022-2029
  • FIG 6. Global Precision Medicine Market, porters 5 force model
  • FIG 7. Global Precision Medicine Market, pest analysis
  • FIG 8. Global Precision Medicine Market, value chain analysis
  • FIG 9. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Precision Medicine Market, regional snapshot 2019 & 2029
  • FIG 15. North America Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Precision Medicine Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable